RTI Surgical (RTIX) Reports In-Line Q3 EPS; Trims FY15 Outlook

RTI Surgical (NASDAQ: RTIX) reported Q3 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $66.5 million versus the consensus estimate of $69.53 million.

RTI Surgical sees FY2015 EPS of $0.19, versus prior guidance of $0.20-$0.23 and the consensus of $0.21. RTI Surgical sees FY2015 revenue of $274-275 million, versus prior guidance of $282-286 million and the consensus of $284.5 million.

RTI Surgical sees Q4 2015 EPS of $0.05, versus the consensus of $0.07. RTI Surgical sees Q4 2015 revenue of $68-69 million, versus the consensus of $75.0 million.

For earnings history and earnings-related data on RTI Surgical (RTIX) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth